| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.067 | 0.2 |